Achieve Life Sciences (ACHV) Receivables (2010 - 2021)

Achieve Life Sciences (ACHV) recorded quarterly Receivables of $351000.0 in Q3 2021, up 4287.5% on a QoQ basis from $8000.0 in Q4 2019.

Achieve Life Sciences (ACHV) Receivables (2010 - 2021) Analysis & Trends

Achieve Life Sciences has disclosed Receivables across 11 years of filings, most recently posting $351000.0 for Q3 2021.

  • Quarterly Receivables changed N/A year-over-year to $351000.0 in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $351000.0 (changed N/A YoY) and the FY2019 annual result came in at $8000.0, up 14.29% from the prior year.
  • Receivables climbed to $351000.0 in Q3 2021, from $8000.0 in the prior quarter.
  • Over five years, Receivables peaked at $351000.0 in Q3 2021 and troughed at $7000.0 in Q1 2018.
  • A 4-year average of $107900.0 and a median of $47500.0 in 2017 frame the typical range for Receivables.
  • Annual changes were most pronounced in 2017 — Receivables slumped 98.24% — and 2019, when it increased 14.29%.
  • Tracing ACHV's Receivables over 4 years: stood at $9000.0 in 2017, then dropped by 22.22% to $7000.0 in 2018, then gained by 14.29% to $8000.0 in 2019, then surged by 4287.5% to $351000.0 in 2021.
  • Business Quant data shows ACHV's Receivables at $351000.0 in Q3 2021, $8000.0 in Q4 2019, and $7000.0 in Q4 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 13.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 2.00 Bn
9 Abivax 91.71 Bn 91.71 Bn - -
10 Achieve Life Sciences 93.71 Mn 63.22 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2021 351,000.00
Dec 31, 2019 8,000.00
Dec 31, 2018 7,000.00
Sep 30, 2018 25,000.00
Jun 30, 2018 124,000.00
Mar 31, 2018 7,000.00
Dec 31, 2017 9,000.00
Sep 30, 2017 70,000.00
Jun 30, 2017 241,000.00
Mar 31, 2017 237,000.00
Dec 31, 2016 510,000.00
Dec 31, 2015 125,000.00
Sep 30, 2015 61,000.00
Jun 30, 2015 225,000.00
Mar 31, 2015 1.63 Mn
Dec 31, 2014 5.79 Mn
Sep 30, 2014 4.85 Mn
Jun 30, 2014 4.95 Mn
Mar 31, 2014 8.78 Mn
Dec 31, 2013 8.88 Mn